Alzheimer’s Disease: Progress in Biomarkers, Diagnostics and Therapies
Open Access
- 8 September 2026
- book chapter
- Published by Springer Nature
- p. 125-151
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Evaluating the association of apolipoprotein E genotype and cognitive resilience in SuperAgersAlzheimer's & Dementia, 2026
- Amyloid-Beta Pathology and Cognitive Performance in CentenariansJAMA Neurology, 2025
- 2025 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2025
- Plasma Aβ 42 /Aβ 40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrumAlzheimer's & Dementia, 2024
- Alzheimer Disease as a Clinical-Biological Construct—An International Working Group RecommendationJAMA Neurology, 2024
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Effectiveness of Personalized Hippocampal Network–Targeted Stimulation in Alzheimer DiseaseJAMA Network Open, 2024
- Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyJAMA Neurology, 2024
- Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB‐JAlzheimer's & Dementia, 2022
- Human Memory and the Cholinergic SystemArchives of Neurology, 1974